Alector (ALEC) Other Accumulated Expenses (2018 - 2025)
Alector's (ALEC) quarterly Other Accumulated Expenses came in at $495000.0 in Q4 2025, up 2.7% year-over-year from $482000.0 in Q4 2024, and up 2.7% quarter-over-quarter from $482000.0 in Q4 2024.
Analysis
Alector (ALEC) Other Accumulated Expenses (2018 - 2025) Analysis & Trends
Alector (ALEC) has reported Other Accumulated Expenses for 8 consecutive years, with $495000.0 the latest figure, recorded in Q4 2025.
- On a quarterly basis, Other Accumulated Expenses rose 2.7% year-over-year to $495000.0 in Q4 2025; TTM through Dec 2025 was $495000.0, a 2.7% increase from a year earlier, with the FY2025 full-year figure at $495000.0, up 2.7% from the prior year.
- Other Accumulated Expenses was $495000.0 for Q4 2025 at Alector, up from $482000.0 in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $709000.0 in Q4 2022 and troughed at $318000.0 in Q4 2021.
- A 5-year average of $485400.0 and a median of $482000.0 in 2024 frame the typical range for Other Accumulated Expenses.
- Across the five-year window, Other Accumulated Expenses soared 122.96% in 2022 and plunged 40.34% in 2023, its largest moves.
- Over 5 years, Other Accumulated Expenses stood at $318000.0 in 2021, then jumped by 122.96% to $709000.0 in 2022, then tumbled by 40.34% to $423000.0 in 2023, then increased by 13.95% to $482000.0 in 2024, then gained by 2.7% to $495000.0 in 2025.
- The last three Other Accumulated Expenses figures came in at $495000.0 (Q4 2025), $482000.0 (Q4 2024), and $423000.0 (Q4 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 495,000.00 |
| Dec 31, 2024 | 482,000.00 |
| Dec 31, 2023 | 423,000.00 |
| Dec 31, 2022 | 709,000.00 |
| Dec 31, 2021 | 318,000.00 |
| Dec 31, 2020 | 353,000.00 |
| Dec 31, 2019 | 615,000.00 |
| Sep 30, 2019 | 122,000.00 |
| Jun 30, 2019 | 156,000.00 |
| Mar 31, 2019 | 165,000.00 |
| Dec 31, 2018 | 971,000.00 |